Non-Myeloablative Allogeneic Stem Cell Transplantation With Matched Unrelated Donors for Treatment of Hematologic Malignancies, Renal Cell Carcinoma, and Aplastic Anemia
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to Acute Myeloid Leukemia
Related studies linked through entity extraction aliases.
Study to Assess the Safety, Tolerability, and Efficacy of Tipifarnib Plus Bortezomib in the Treatment of Acute Myeloid Leukemia
- Status
- UNKNOWN
- Phase
- PHASE2
Treosulfan-based Conditioning for Transplantation in AML/MDS
- Status
- COMPLETED
- Phase
- PHASE2
Fludarabine, Cytarabine, Topotecan in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE4
Oxaliplatin, Fludarabine, and Cytarabine in Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndromes (MDS)
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Lomustine and Intermediate Dose Cytarabine in Older Patients With AML
- Status
- COMPLETED
- Phase
- PHASE3
NOPHO-AML 2004 Study for Children With Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE3
Efficacy and Safety Study of StemEx®, to Treat Subjects With High Risk Hematologic Malignancies, Following Myeloablative Therapy
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
IV Busulfan With Allo-BMT: Study for Patients With Acute Myelogenous Leukemia and Myelodysplastic Syndrome
- Status
- COMPLETED
- Phase
- PHASE3
Busulfan, Fludarabine, Clofarabine With Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
Lenalidomide in Acute Leukemias and Chronic Lymphocytic Leukemia.
- Status
- COMPLETED
- Phase
- PHASE1
A Phase I Study of AC220 in Patients With Relapsed/Refractory Acute Myeloid Leukemia Regardless of FLT3 Status
- Status
- COMPLETED
- Phase
- PHASE1
Allogeneic Cytokine-induced Killer Immunotherapy for Relapse After Allogeneic Marrow Transplant for Haematological Malignancies
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Gemtuzumab Ozogamicin Before Allogeneic Stem Cell Transplantation
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Intermittent Liposomal Amphotericin B Primary Prophylaxis
- Status
- UNKNOWN
- Phase
- PHASE2
Timed-Sequential Induction in CBF-AML
- Status
- COMPLETED
- Phase
- PHASE3
Standard Idarubicin and Cytarabine for the Treatment of Acute Myeloid Leukemia (AML)
- Status
- COMPLETED
- Phase
- PHASE2
Decitabine as Maintenance Therapy After Standard Therapy in Treating Patients With Previously Untreated Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
Safety, Efficacy and Pharmacokinetics of an Antifungal in Patients Undergoing Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Autologous Cytokine-induced Killer Cell Adoptive Immunotherapy for Acute Myeloid Leukemia and Myelodysplastic Syndrome
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2